Restricted accessResearch articleFirst published online 2026-1
Balancing present-moment acceptance and future concerns: A qualitative study of illness experiences and perceptions of palliative care in progressive neurological diseases
Palliative care is advocated for improving quality of life and symptom control in people with progressive neurological diseases. However, most research has been conducted in Western culture, leaving a gap in Asian contexts. Understanding illness experience and perceived needs is essential for developing culturally tailored palliative interventions.
Aim:
To explore the lived experience of people with progressive neurological diseases in Hong Kong and their perceptions of palliative care.
Design:
Qualitative study using an interpretive description approach and thematic analysis.
Setting/participants:
Twenty-five patients (10 Parkinson’s disease; 15 multiple sclerosis) were interviewed from August to October 2022.
Results:
Four themes were identified: (1) struggles with “invisible pain”: living with unpredictability and uncontrollability; (2) renegotiating life amid progressive loss of functions; (3) a desire for person-centered holistic care, and (4) dilemmas in future care planning amid limited awareness of palliative care. Participants experienced profound psychospiritual distress, disrupted self-identity, and social disconnection. While seeking acceptance and a positive outlook, they felt their holistic needs were overlooked by a healthcare system focused mainly on physical symptoms. Most were unfamiliar with palliative care, viewing it as irrelevant to progressive neurological diseases, yet desired compassionate, whole-person care, including psychospiritual support. Despite recognizing the need for future care planning before cognitive decline, barriers including emotional burden, family reluctance, and limited information impeded open discussions.
Conclusions:
Progressive neurological diseases significantly affect psychospiritual and social wellbeing. A person-centered, symptom-based palliative care approach, tailored to the fluctuating trajectory of progressive neurological diseases, is essential to address these multidimensional needs.
SteinmetzJDSeeherKMSchiessN.Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol2024; 23: 344–381.
2.
GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol2017; 16: 877–897. DOI: 10.1016/S1474-4422(17)30299-5. 20170917.
3.
KwokJYYAuyeungMChanHYL. Examining factors related to health-related quality of life in people with Parkinson’s disease. Rehabil Nurs2020; 45: 122–130.
4.
KwokJYYHuangTWTretriluxanaJ, et alSymptom Burden and unmet support needs of patients with Parkinson’s disease: a cross-sectional study in Asia-Pacific regions. J Am Med Dir Assoc2021; 22: 1255–1264.
5.
SaleemTLeighPNHigginsonIJ.Symptom prevalence among people affected by advanced and progressive neurological conditions–a systematic review. J Palliat Care2007; 23: 291–299.
6.
KlugerBMHudsonPHansonLC, et alPalliative care to support the needs of adults with neurological disease. Lancet Neurol2023; 22: 619–631.
7.
CrowleyEKNolanYMSullivanAM.Exercise as a therapeutic intervention for motor and non-motor symptoms in Parkinson’s disease: Evidence from rodent models. Prog Neurobiol2019; 172: 2–22.
8.
JankovicJ.Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry2008; 79: 368–376.
9.
TarolliCGZimmermanGAAuingerP, et alSymptom burden among individuals with Parkinson disease: A national survey. Neurol Clin Pract2020; 10: 65–72.
10.
FilippiMBar-OrAPiehlF, et alMultiple sclerosis. Nat Rev Dis Primers2018; 4: 43.
11.
MercadanteS.Palliative care aspects in multiple sclerosis. J Pain Symptom Manag2024; 67: e425–e437.
12.
KwokJYYLeeJJAuyeungM, et alLetting nature take its course: a qualitative exploration of the illness and adjustment experiences of Hong Kong Chinese people with Parkinson’s disease. Health Soc Care Community2020; 28: 2343–2351.
13.
HinnellCHurtCSLandauS, et alNonmotor versus motor symptoms: how much do they matter to health status in Parkinson’s disease?Mov Disord2012; 27: 236–241.
14.
TaylorLPBesbrisJMGrafWD, et alClinical guidance in neuropalliative care: an AAN position statement. Neurol2022; 98: 409–416.
15.
FerrellBRTwaddleMLMelnickA, et alNational consensus project clinical practice guidelines for quality palliative care guidelines, 4th edition. J Palliat Med2018; 21: 1684–1689.
16.
KavalieratosDCorbelliJZhangD, et alAssociation between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis. JAMA2016; 316: 2104–2114.
17.
QuinnKLShurrabMGitauK, et alAssociation of receipt of palliative care interventions with health care use, quality of life, and symptom burden among adults with chronic noncancer illness: A systematic review and meta-analysis. JAMA2020; 324: 1439–1450.
18.
OliverDJBorasioGDCaraceniA, et alA consensus review on the development of palliative care for patients with chronic and progressive neurological disease. Eur J Neurol2016; 23: 30–38.
19.
ChanLMLYanOYLeeJJJ, et alEffects of palliative care for progressive neurologic diseases: a systematic review and meta-analysis. J Am Med Dir Assoc2023; 24: 171–184.
20.
VeroneseSGalloGValleA, et alSpecialist palliative care improves the quality of life in advanced neurodegenerative disorders: NE-PAL, a pilot randomised controlled study. BMJ Support Palliat Care2017; 7: 164–172.
21.
GaoWWilsonRHepgulN, et alEffect of short-term integrated palliative care on patient-reported outcomes among patients severely affected with long-term neurological conditions: A randomized clinical trial. JAMA Netw Open2020; 3: e2015061.
22.
KlugerBMMiyasakiJKatzM, et alComparison of integrated outpatient palliative care with standard care in patients with Parkinson disease and related disorders: a randomized clinical trial. JAMA Neurol2020; 77: 551–560.
23.
KlugerBMShattuckJBerkJ, et alDefining palliative care needs in Parkinson’s disease. Mov Disord Clin Pract2019; 6: 125–131.
24.
SaleemTZHigginsonIJChaudhuriKR, et alSymptom prevalence, severity and palliative care needs assessment using the palliative outcome scale: a cross-sectional study of patients with Parkinson’s disease and related neurological conditions. Palliat Med2013; 27: 722–731.
25.
BužgováRKozákováRJuríčkováL.The unmet needs of patients with progressive neurological diseases in the Czech Republic: a qualitative study. J Palliat Care2019; 34: 38–46.
26.
VeroneseSGalloGValleA, et alThe palliative care needs of people severely affected by neurodegenerative disorders: a qualitative study. Prog Palliat Care2015; 23: 331–342.
27.
BoersmaIJonesJCarterJ, et alParkinson disease patients’ perspectives on palliative care needs: what are they telling us?Neurol Clin Pract2016; 6: 209–219.
28.
ZhouQLeiYTianL, et alPerception and sentiment analysis of palliative care in Chinese social media: qualitative studies based on machine learning. Soc Sci Med2025; 379: 118178.
29.
WangYZhangXHuangY, et alPalliative care for cancer patients in Asia: challenges and countermeasures. Oncol Rev2023; 17: 11866.
30.
KwokHHYLowJDevakumarD, et alExperience and perspectives on palliative or end-of-life care of Chinese people and their families as immigrants to high-income countries: a systematic review and thematic synthesis. BMJ Glob Health2020; 5: e003232. DOI: 10.1136/bmjgh-2020-003232
31.
PayneSChapmanAHollowayM, et alChinese community views: promoting cultural competence in palliative care. J Palliat Care2005; 21: 111–116.
32.
ChengS-YLinC-PChanHY, et alAdvance care planning in Asian culture. Jpn J Clin Oncol2020; 50: 976–989.
33.
ThorneSStephensJTruantT.Building qualitative study design using nursing’s disciplinary epistemology. J Adv Nurs2016; 72: 451–460.
34.
ThorneS.Interpretive description: Qualitative research for applied practice, 2nd ed. 2016, pp.1–336.
35.
LeeJJThorneS.Interpretive description: a rigorous approach to qualitative research in the applied disciplines In: Wa-MbalekaSRosarioA (eds) The SAGE Handbook of Qualitative Research in the Asian Context. London: SAGE Publications Ltd, 2022, pp.308–324.
36.
JitapunkulSPillayIEbrahimS.The abbreviated mental test: its use and validity. Age Ageing1991; 20: 332–336.
37.
ChanLMLChoiEPHLamWWT, et alPalliative care need and quality of life mediated by psychological distress in neurologic diseases. J Pain Symptom Manag2025; 69: 641–653.e3.
38.
EtikanISulaiman AbubakarMRukayya SunusiA.Comparison of convenience sampling and purposive sampling. Am J Theor Appl Stat2016; 5(1): 4.
39.
BraunVClarkeV.Using thematic analysis in psychology. Qual Res Psychol2006; 3: 77–101.
40.
LeeJJRamjanLNuampaS, et alWhere is the interpretation? Important considerations for the philosophical and disciplinary lens in qualitative health research. Nurs Health Sci2023; 25: 493–496.
41.
KorostilMFeinsteinA.Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler2007; 13: 67–72.
42.
LeventhalHPhillipsLABurnsE.The common-sense model of self-regulation (CSM): a dynamic framework for understanding illness self-management. J Behav Med2016; 39: 935–946.
43.
TimkovaVMikulaPFedicovaM, et alPsychological well-being in people with multiple sclerosis and its association with illness perception and self-esteem. Multiple Scler Relat Disord2021; 54: 103114.
44.
EvansDNormanP.Illness representations, coping and psychological adjustment to Parkinson’s disease. Psychol Health2009; 24: 1181–1196.
45.
LucaMEcclesFPerez AlgortaG, et alIllness perceptions and outcome in multiple sclerosis: a systematic review of the literature. Multiple Scler Relat Disord2022; 67: 104180.
46.
VaughanRMorrisonLMillerE.The illness representations of multiple sclerosis and their relations to outcome. Br J Health Psychol2003; 8: 287–301.
47.
DesboroughJBrunoroCParkinsonA, et al‘It struck at the heart of who I thought I was’: a meta-synthesis of the qualitative literature examining the experiences of people with multiple sclerosis. Health Expect2020; 23: 1007–1027.
48.
WieringaGDaleMEcclesFJR. Adjusting to living with Parkinson’s disease; a meta-ethnography of qualitative research. Disabil Rehabil2022; 44: 6949–6968.
49.
MeekCTopcuGMoghaddamN, et alExperiences of adjustment to secondary progressive multiple sclerosis: a meta-ethnographic systematic review. Disabil Rehabil2021; 43: 3135–3146.
50.
KangMYEllis-HillC.How do people live life successfully with Parkinson’s disease?J Clin Nurs2015; 24: 2314–2322.
51.
BogosianAMorganMBishopFL, et alAdjustment modes in the trajectory of progressive multiple sclerosis: a qualitative study and conceptual model. Psychol Health2017; 32: 343–360.
52.
BadantaBGonzález-Cano-CaballeroMSuárez-ReinaP, et alHow does Confucianism influence health behaviors, health outcomes and medical decisions? A scoping review. J Relig Health2022; 61: 2679–2725.
53.
MorlingBEveredS.Secondary control reviewed and defined. Psychol Bull2006; 132: 269–296.
54.
CompasBEJaserSSDunnMJ, et alCoping with chronic illness in childhood and adolescence. Annu Rev Clin Psychol2012; 8: 455–480.
55.
McQuillenADLichtMHLichtBG.Contributions of disease severity and perceptions of primary and secondary control to the prediction of psychosocial adjustment to Parkinson’s disease. Health Psychol2003; 22: 504–512.
56.
HaahrAGroosHSørensenD.‘Striving for normality’ when coping with Parkinson’s disease in everyday life: A metasynthesis. Int J Nurs Stud2021; 118: 103923.
57.
LuLLiuJYuanYC.Cultural differences in cancer information acquisition: Cancer Risk Perceptions, fatalistic beliefs, and worry as predictors of cancer information seeking and avoidance in the U.S. and China. Health Commun2022; 37: 1442–1451.
58.
MengMLiXZhaoJ, et alWhen western concept meets eastern culture: Exploring the impact of Confucianism on shared decision-making in China. Asia Pac J Oncol Nurs2024; 11: 100586–20240902.
59.
ClassenCButlerLDKoopmanC, et alSupportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch Gen Psychiatry2001; 58: 494–501.
60.
BreitbartWGibsonCPoppitoSR, et alPsychotherapeutic interventions at the end of life: a focus on meaning and spirituality. Can J Psychiatry2004; 49: 366–372.
61.
Vann-WardTMorseJMCharmazK.Preserving Self: theorizing the social and psychological processes of living with Parkinson disease. Qual Health Res2017; 27: 964–982.
62.
SmithLJShawRL.Learning to live with Parkinson’s disease in the family unit: an interpretative phenomenological analysis of well-being. Med Health Care Philos2017; 20: 13–21.
63.
GrahamCDGouickJKrahéC, et alA systematic review of the use of acceptance and Commitment Therapy (ACT) in chronic disease and long-term conditions. Clin Psychol Rev2016; 46: 46–58.
64.
ChenDRYoungYShayyaA, et alCultural interplay in end-of-life care decisions: comparing advance directive beliefs and preferences among adults in the U.S. and Taiwan. BMC Palliat Care2025; 24: 104.
65.
ChungRYNWongELYKiangN, et alKnowledge, attitudes, and preferences of advance decisions, End-of-Life care, and place of care and death in Hong Kong. A population-based telephone survey of 1067 Adults. J Am Med Dir Assoc2017; 18: 367.e19–367.e327.
66.
AikenLSButnerJLockhartCA, et alOutcome evaluation of a randomized trial of the PhoenixCare intervention: program of case management and coordinated care for the seriously chronically ill. J Palliat Med2006; 9: 111–126.
67.
MüllerAHebbenFDillenK, et alSo at least now I know how to deal with things myself, what I can do if it gets really bad again”—experiences with a long-term cross-sectoral advocacy care and case management for severe multiple sclerosis: a qualitative study. BMC Health Serv Res2024; 24: 453.
68.
GollaHDillenKHellmichM, et alCommunication, coordination, and security for people with multiple sclerosis (COCOS-MS): a randomised phase II clinical trial protocol. BMJ Open2022; 12: e049300.
69.
GollaHDunklVDorrA, et alCommunication, coordination, and security for people with multiple sclerosis (COCOS-MS): A randomized, Phase II trial of cross-sectoral care and Case Management. Dtsch Arztebl Int2025; 122: 489–494.
70.
GollaHGalushkoMPfaffH, et alMultiple sclerosis and palliative care - perceptions of severely affected multiple sclerosis patients and their health professionals: a qualitative study. BMC Palliat Care2014; 13: 11.
71.
StruppJVoltzRGollaH.Opening locked doors: integrating a palliative care approach into the management of patients with severe multiple sclerosis. Multiple Scler J2016; 22: 13–18.
72.
CheongWLMohanDWarrenN, et alAccessing palliative care for multiple sclerosis: a qualitative study of a neglected neurological disease. Multiple Scler Relat Disord2019; 35: 86–91.
73.
ChenYZhangRLouY, et alFacilitators and barriers to the delivery of palliative care to patients with Parkinson’s disease: a qualitative study of the perceptions and experiences of stakeholders using the socio-ecological model. BMC Health Serv Res2023; 23: 215.
74.
ChosichBBurgessMEarnestA, et alCancer patients’ perceptions of palliative care. Support Care Cancer2020; 28: 1207–1214.
75.
LingMWangXMaY, et alA review of the current state of Hospice Care in China. Curr Oncol Rep2020; 22: 99.
76.
ZimmermannCSwamiNKrzyzanowskaM, et alPerceptions of palliative care among patients with advanced cancer and their caregivers. CMAJ2016; 188: E217–E227.
SeymourJ.The impact of public health awareness campaigns on the awareness and quality of palliative care. J Palliat Med2018; 21: S30–s36.
79.
FriedTRReddingCARobbinsML, et alDevelopment of personalized health messages to promote engagement in advance care planning. J Am Geriatr Soc2016; 64: 359–364.
80.
HallKSumrallMThelenG, et alPalliative care for Parkinson’s disease: suggestions from a council of patient and carepartners. NPJ Parkinsons Dis2017; 3: 16.
81.
SteiglederTKollmarROstgatheC.Palliative care for stroke patients and their families: barriers for implementation. Front Neurol2019; 10: 164.
82.
OliverDVeroneseS.Specialist palliative care for Parkinson’s disease. Ann Palliat Med2020; 9: S52–s62.
83.
FoxSCashellAKernohanWG, et alPalliative care for Parkinson’s disease: patient and carer’s perspectives explored through qualitative interview. Palliat Med2017; 31: 634–641.
84.
PunJKHChanEAWangS, et alHealth professional-patient communication practices in East Asia: an integrative review of an emerging field of research and practice in Hong Kong, South Korea, Japan, Taiwan, and Mainland China. Patient Educ Couns2018; 101: 1193–1206.
85.
CreutzfeldtCJKlugerBKellyAG, et alNeuropalliative care: priorities to move the field forward. Neurol2018; 91: 217–226.
86.
CreutzfeldtCJKlugerBMHollowayRG.Neuropalliative care a guide to improving the lives of patients and families affected by neurologic disease. Springer, 2019.
87.
CreutzfeldtCJRobinsonMTHollowayRG.Neurologists as primary palliative care providers: communication and practice approaches. Neurol Clin Pract2016; 6: 40–48.
88.
OliverDBorasioGDVeroneseS, et alCurrent collaboration between palliative care and neurology: a survey of clinicians in Europe. BMJ Support Palliat Care2024; 14: e743–e748.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
